| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.30B | 24.38B | 23.86B | 23.95B | 23.22B | 22.50B |
| Gross Profit | 8.72B | 8.68B | 7.16B | 9.07B | 9.82B | 9.31B |
| EBITDA | 2.99B | 2.86B | 1.70B | 3.01B | 4.17B | 4.59B |
| Net Income | 1.58B | 1.51B | 603.18M | 1.44B | 2.05B | 2.46B |
Balance Sheet | ||||||
| Total Assets | 20.71B | 21.43B | 22.95B | 21.42B | 20.96B | 20.55B |
| Cash, Cash Equivalents and Short-Term Investments | 12.59B | 12.83B | 13.84B | 13.20B | 12.94B | 11.93B |
| Total Debt | 5.57M | 6.66M | 9.91M | 13.99M | 8.68M | 57.97M |
| Total Liabilities | 6.97B | 7.19B | 8.73B | 6.67B | 6.22B | 6.51B |
| Stockholders Equity | 13.74B | 14.24B | 14.22B | 14.74B | 14.75B | 14.04B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 987.74M | 1.96B | 1.63B | 2.36B | 3.79B |
| Operating Cash Flow | 0.00 | 1.21B | 2.29B | 2.22B | 3.25B | 4.12B |
| Investing Cash Flow | 0.00 | -267.84M | -764.20M | -581.21M | -876.90M | -330.11M |
| Financing Cash Flow | 0.00 | -1.46B | -1.46B | -1.46B | -1.50B | -1.42B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥65.89B | 18.88 | 17.96% | 1.83% | 13.23% | 16.07% | |
76 Outperform | ¥22.82B | 11.39 | ― | 1.70% | 22.25% | 31.88% | |
72 Outperform | ¥29.89B | 13.94 | ― | 3.40% | 12.64% | 30.73% | |
68 Neutral | ¥38.30B | -348.86 | ― | 3.99% | 1.27% | 26.79% | |
68 Neutral | ¥5.58B | 26.17 | ― | 1.23% | 11.62% | -16.59% | |
65 Neutral | ¥30.97B | 10.75 | 10.34% | 4.82% | -3.03% | 38.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |